Showing results (1-10 of 527) with videos related to
Sort By:
Pageof 53
Medical Care|April 17, 1998
SF-36 summary scores: are physical and mental health truly distinct?G E Simon, D A Revicki, L Grothaus, et al.The Journal of Family Practice|December 29, 1998
Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatmentD A Revicki, G E Simon, K Chan, et al.Journal of Psychiatry & Neuroscience : JPN|July 1, 1997
Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophreniaD A RevickiSchizophrenia Research|April 6, 1999
Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophreniaD A RevickiCurrent Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidenceD A RevickiThe Journal of Family Practice|October 1, 1989
Health-related quality of life in the evaluation of medical therapy for chronic illnessD A RevickiMedical Care|May 1, 1992
Relationship between health utility and psychometric health status measuresD A RevickiExpert Opinion on Pharmacotherapy|March 16, 2001
The new atypical antipsychotics: a review of pharmacoeconomic studiesD A RevickiThe Journal of Clinical Psychiatry|February 26, 1999
Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studiesD A RevickiPageof 53